Scientists are to search for special individuals whose innate immune systems provide a powerful defence against cancer.
Their cancer resistance mirrors that of a mutant lab mouse that astonished researchers with its ability to shrug off aggressive cancers.
The bold plan is to use white blood cells from these people – who make up a tiny fraction of the population – to develop a potential cure for pancreatic cancer in the next four years.
The disease has one of the highest fatality rates of any cancer, with only 3.3% of patients surviving five years after diagnosis. Read more . . .